What does CCNA mean in NEUROLOGY
The Canadian Consortium on Neurodegeneration in Aging (CCNA) is a cross-sectoral initiative bringing together organizations from across the country to develop and implement research, policies and services related to Alzheimer's disease, other dementias and aging. The CCNA seeks to understand the symptomatic pathways of these conditions, develop and evaluate interventions to better serve those affected by them, and build capacity among healthcare providers across Canada.
CCNA meaning in Neurology in Medical
CCNA mostly used in an acronym Neurology in Category Medical that means Canadian Consortium on Neurodegeneration in Aging
Shorthand: CCNA,
Full Form: Canadian Consortium on Neurodegeneration in Aging
For more information of "Canadian Consortium on Neurodegeneration in Aging", see the section below.
Essential Questions and Answers on Canadian Consortium on Neurodegeneration in Aging in "MEDICAL»NEUROLOGY"
What is the CCNA?
The CCNA is the Canadian Consortium on Neurodegeneration in Aging — a cross-sectoral initiative bringing together organizations from across the country to develop and implement research, policies and services related to Alzheimer's disease, other dementias and aging.
What are the goals of the CCNA?
The CCNA seeks to understand the symptomatic pathways of these conditions, develop and evaluate interventions to better serve those affected by them, and build capacity among healthcare providers across Canada.
Who is involved in the CCNA?
A variety of organizations from all sectors — including not-for-profit organizations, universities, research institutes, private sector entities and government institutions — are working collaboratively within the consortium.
Final Words:
:The Canadian Consortium on Neurodegeneration in Aging (CCNA) plays an essential role in helping Canadians who "are affected or at risk" of debilitating chronic diseases like Alzheimer's or other dementias by engaging various stakeholders at regional and national level across healthcare systems. With their collaborative efforts they strive to improve outcomes through evidence-based research methods that help find solutions for reducing symptoms associated with neurodegenerative diseases while also improving access to quality care worldwide.